Clarity Pharmaceuticals Ltd (ASX: CU6) — Healthcare · Share Price, Chart & Market Data
About: Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$3.11 (+5.78%)
CU6Clarity Pharmaceuticals Ltd
Loading watchlist status…
Trade CU6 now
Clarity Pharmaceuticals Ltd share price
CU6 price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:39 pm GMT+0
CU6 price performance
3.667%
5D
-4.893%
1M
-16.173%
YTD
48.095%
1Y
CU6 price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:39 pm GMT+0
CU6 details
CU6 Market Signals